Find a Clinical Trial
Filter
Takeda footprint
Neonatal care
All genders
0-1
Recruiting now
Department of Obstetrics + Gynecology
Treatment Combination of Durvalumab, Tremelimumab and Enfortumab Vedotin or Durvalumab and Enfortumab Vedotin in Patients With Muscle Invasive Bladder Cancer Ineligible to Cisplatin or Who Refuse Cisplatin (VOLGA)
Bladder cancer
All genders
18+
Recruiting now
Department of Medicine, Cancer Center
BoppliTM blood pressure monitoring
Neonatal care
All genders
0-18
Recruiting now
Department of Pediatrics
The Connection study
Premature babies, Premature birth
All genders
No minimum age
Recruiting now
Department of Obstetrics + Gynecology
Body composition in VLBW infants
All genders
No minimum age
Recruiting now
Department of Pediatrics
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Squamous cell carcinoma
All genders
18+
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
Feasibility of a new method for non-invasive monitoring of low-grade bladder cancer
Bladder cancer
All genders
18-90
Recruiting now
Department of Urology
SPITSS
Sepsis
All genders
No minimum age
Recruiting now
Department of Obstetrics + Gynecology
Infant Vision Health and Prenatal Drug Exposure
Vision health
All genders
0-5
Recruiting now
Department of Obstetrics + Gynecology